Clinical Trials
5
Active:0
Completed:5
Trial Phases
2 Phases
Phase 2:2
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (50.0%)Phase 2
2 (50.0%)The Effects of a Novel Probiotic on Gastrointestinal Health in Generally Healthy Adults
Not Applicable
Completed
- Conditions
- Immune HealthDigestive HealthGastrointestinal Health
- First Posted Date
- 2022-10-27
- Last Posted Date
- 2023-02-06
- Lead Sponsor
- BIO-CAT Microbials, LLC
- Target Recruit Count
- 80
- Registration Number
- NCT05595980
- Locations
- 🇺🇸
Biofortis Clinical Research, Inc., Addison, Illinois, United States
Effect of Bacillus Subtilis BS50 Supplementation on Gastrointestinal Symptoms in Healthy Adults
Not Applicable
Completed
- Conditions
- Gastrointestinal HealthCardiovascular HealthImmune HealthDigestive Health
- First Posted Date
- 2021-08-13
- Last Posted Date
- 2023-01-05
- Lead Sponsor
- BIO-CAT Microbials, LLC
- Target Recruit Count
- 76
- Registration Number
- NCT05004454
- Locations
- 🇺🇸
Biofortis, Merieux Nutrisciences, Addison, Illinois, United States
A Study to Evaluate the Effect of GFA-918 on Serum Triglyceride Levels in Individuals With Elevated Serum Triglyceride
Phase 2
Completed
- Conditions
- Elevated Triglycerides
- First Posted Date
- 2021-02-15
- Last Posted Date
- 2021-12-22
- Lead Sponsor
- BIO-CAT Microbials, LLC
- Target Recruit Count
- 37
- Registration Number
- NCT04754373
- Locations
- 🇨🇦
KGK Science, London, Ontario, Canada
🇨🇦Canadian College of Naturopathic Medicine, Toronto, Ontario, Canada
Safety and Tolerability of Bacillus Subtilis MB40 in Healthy Adult Volunteers
Completed
- Conditions
- Healthy Participants
- First Posted Date
- 2020-12-07
- Last Posted Date
- 2022-02-10
- Lead Sponsor
- BIO-CAT Microbials, LLC
- Target Recruit Count
- 30
- Registration Number
- NCT04655352
A Study to Evaluate OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population
Phase 2
Completed
- Conditions
- Bloating
- First Posted Date
- 2016-10-31
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- BIO-CAT Microbials, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT02950012
- Locations
- 🇺🇸
KGK Clinical Trials Center, Orlando, Florida, United States
🇨🇦KGK Synergize Inc., London, Ontario, Canada
News
No news found